DK0391625T3 - Substituerede chromaner til behandling af astma, arthritis og beslægtede sygdomme - Google Patents
Substituerede chromaner til behandling af astma, arthritis og beslægtede sygdommeInfo
- Publication number
- DK0391625T3 DK0391625T3 DK90303443.7T DK90303443T DK0391625T3 DK 0391625 T3 DK0391625 T3 DK 0391625T3 DK 90303443 T DK90303443 T DK 90303443T DK 0391625 T3 DK0391625 T3 DK 0391625T3
- Authority
- DK
- Denmark
- Prior art keywords
- arthritis
- substituted
- chromana
- related diseases
- treat asthma
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1989/001457 WO1990012010A1 (en) | 1989-04-07 | 1989-04-07 | Substituted chromans in the treatment of asthma, arthritis and related diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0391625T3 true DK0391625T3 (da) | 1994-02-28 |
Family
ID=22214926
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK90303443.7T DK0391625T3 (da) | 1989-04-07 | 1990-03-30 | Substituerede chromaner til behandling af astma, arthritis og beslægtede sygdomme |
Country Status (12)
Country | Link |
---|---|
US (1) | US5298512A (da) |
EP (1) | EP0391625B1 (da) |
JP (1) | JPH0753726B2 (da) |
AT (1) | ATE100804T1 (da) |
CA (1) | CA2013894A1 (da) |
DE (1) | DE69006243T2 (da) |
DK (1) | DK0391625T3 (da) |
ES (1) | ES2062345T3 (da) |
FI (1) | FI914683A0 (da) |
IE (1) | IE901241L (da) |
PT (1) | PT93674A (da) |
WO (1) | WO1990012010A1 (da) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2676056B1 (fr) * | 1991-05-03 | 1993-07-16 | Adir | Nouveaux derives du benzopyranne leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
US5149703A (en) * | 1991-09-06 | 1992-09-22 | Merck Frosst Canada, Inc. | Quinoline-substituted chromans and related compounds as leukotriene antagonists |
MX9300312A (es) * | 1992-01-23 | 1993-07-31 | Pfizer | Antagonistas benzopiranicos y relacionado de ltb. |
US5451603A (en) * | 1993-03-11 | 1995-09-19 | Zymogenetics, Inc. | 3,4-diarylchromans for treatment of dermatitis |
US5698550A (en) * | 1993-06-14 | 1997-12-16 | Pfizer Inc. | Tetralin and chroman derivatives useful in the treatment of asthma, arthritis and related diseases |
US5482942A (en) * | 1994-06-28 | 1996-01-09 | American Home Products Corporation | (3,4-dioxocyclobuten-1-yl)chromene, indene, and dihydronaphthalenone derivatives as smooth muscle relaxants |
US5952326A (en) * | 1997-12-10 | 1999-09-14 | Pfizer Inc. | Tetralin and chroman derivatives useful in the treatment of asthma, arthritis and related diseases |
CA2375275A1 (en) | 1999-06-22 | 2000-12-28 | Mount Sinai Hospital | Difuropyrone derivatives |
US20060019269A1 (en) * | 2002-10-17 | 2006-01-26 | Decode Genetics, Inc. | Susceptibility gene for myocardial infarction, stroke, and PAOD, methods of treatment |
US7851486B2 (en) * | 2002-10-17 | 2010-12-14 | Decode Genetics Ehf. | Susceptibility gene for myocardial infarction, stroke, and PAOD; methods of treatment |
WO2004035741A2 (en) * | 2002-10-17 | 2004-04-29 | Decode Genetics Ehf. | Susceptibility gene for myocardial infarction; methods of treatment |
US20080293750A1 (en) * | 2002-10-17 | 2008-11-27 | Anna Helgadottir | Susceptibility Gene for Myocardial Infarction, Stroke, Paod and Methods of Treatment |
US7507531B2 (en) * | 2002-10-17 | 2009-03-24 | Decode Genetics Chf. | Use of 5-lipoxygenase activating protein (FLAP) gene to assess susceptibility for myocardial infarction |
EP1670445A2 (en) * | 2003-09-17 | 2006-06-21 | Decode Genetics EHF. | Methods of preventing or treating recurrence of myocardial infarction |
US20100216863A1 (en) * | 2004-01-30 | 2010-08-26 | Decode Genetics Ehf. | Susceptibility Gene for Myocardial Infarction, Stroke, and PAOD; Methods of Treatment |
US8158362B2 (en) * | 2005-03-30 | 2012-04-17 | Decode Genetics Ehf. | Methods of diagnosing susceptibility to myocardial infarction and screening for an LTA4H haplotype |
NZ595789A (en) | 2009-04-29 | 2014-05-30 | Amarin Pharmaceuticals Ie Ltd | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same |
US10772652B2 (en) | 2015-01-28 | 2020-09-15 | Covidien Lp | Tissue resection system |
CA2989162A1 (en) | 2015-06-18 | 2016-12-22 | Covidien Lp | Surgical instrument with suction control |
TWI820039B (zh) * | 2017-09-07 | 2023-11-01 | 大陸商恒翼生物醫藥(上海)股份有限公司 | 苯並雜環衍生物及包含其的醫藥組合物 |
US11883058B2 (en) | 2019-03-26 | 2024-01-30 | Covidien Lp | Jaw members, end effector assemblies, and ultrasonic surgical instruments including the same |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3553093A (en) * | 1965-03-19 | 1971-01-05 | Xerox Corp | Color photoelectrophoretic imaging process |
US3936461A (en) * | 1973-09-24 | 1976-02-03 | Warner-Lambert Company | Substituted 4-benzylquinolines |
US4127669A (en) * | 1977-10-13 | 1978-11-28 | Warner-Lambert Company | [(4-Oxo-4H-1-benzopyran-3-yl)oxy] acetic acids and derivatives |
US4563468A (en) * | 1979-09-13 | 1986-01-07 | Burroughs Wellcome Co. | Chemotherapeutic agents |
EP0126311B1 (en) * | 1983-05-18 | 1989-09-13 | Beecham Group Plc | Benzopyran derivatives. |
US4661596A (en) * | 1985-02-21 | 1987-04-28 | American Home Products Corporation | Quinolinyl (or pyridinyl) methoxy substituted naphthalene compounds as antiallergic agents |
US4642347A (en) * | 1985-05-21 | 1987-02-10 | American Home Products Corporation | 3(2-quinolinylalkoxy)phenols |
US4889941A (en) * | 1987-04-23 | 1989-12-26 | Fisons Corporation | Synthetic flavonoids as inhibitors of leukotrienes and 5-lipoxygenase |
US4889871A (en) * | 1987-05-29 | 1989-12-26 | G. D. Searle & Co. | Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives |
MX13485A (es) * | 1987-10-19 | 1993-05-01 | Pfizer | Procedimiento para obtener tetralinas, cromados y compuestos relacionados, sustituidos |
-
1989
- 1989-04-07 WO PCT/US1989/001457 patent/WO1990012010A1/en active Application Filing
- 1989-04-07 US US07/768,622 patent/US5298512A/en not_active Expired - Fee Related
-
1990
- 1990-03-30 AT AT90303443T patent/ATE100804T1/de not_active IP Right Cessation
- 1990-03-30 DK DK90303443.7T patent/DK0391625T3/da active
- 1990-03-30 DE DE90303443T patent/DE69006243T2/de not_active Expired - Fee Related
- 1990-03-30 EP EP90303443A patent/EP0391625B1/en not_active Expired - Lifetime
- 1990-03-30 ES ES90303443T patent/ES2062345T3/es not_active Expired - Lifetime
- 1990-04-05 CA CA002013894A patent/CA2013894A1/en not_active Abandoned
- 1990-04-05 PT PT93674A patent/PT93674A/pt not_active Application Discontinuation
- 1990-04-06 IE IE901241A patent/IE901241L/xx unknown
- 1990-04-06 JP JP2091970A patent/JPH0753726B2/ja not_active Expired - Lifetime
-
1991
- 1991-10-04 FI FI914683A patent/FI914683A0/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DE69006243D1 (de) | 1994-03-10 |
PT93674A (pt) | 1990-11-20 |
US5298512A (en) | 1994-03-29 |
CA2013894A1 (en) | 1990-10-07 |
JPH0753726B2 (ja) | 1995-06-07 |
DE69006243T2 (de) | 1994-05-05 |
EP0391625B1 (en) | 1994-01-26 |
WO1990012010A1 (en) | 1990-10-18 |
JPH02290869A (ja) | 1990-11-30 |
IE901241L (en) | 1990-10-07 |
ATE100804T1 (de) | 1994-02-15 |
EP0391625A1 (en) | 1990-10-10 |
ES2062345T3 (es) | 1994-12-16 |
FI914683A0 (fi) | 1991-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0391625T3 (da) | Substituerede chromaner til behandling af astma, arthritis og beslægtede sygdomme | |
MY104341A (en) | Substituted tetralins,chromans and related compounds in the treatment of asthma,arthritis and related diseases | |
BRPI9917862B8 (pt) | dihidropirimidinas, bem como processo para a preparação e aplicação das mesmas. | |
NO20000762L (no) | Anvendelse av substituerte adeninderivater til behandling av multippel sklerose | |
MX9205573A (es) | Nuevas 9-amino-7-(amino substituido)-6-desmetil-6-desoxitetraciclinas, metodo para su produccion y composicion farmaceutica que las contiene | |
MX9205532A (es) | Nuevas 7-sustituidas-9-amino sustituidas 6-desmetil-6-desoxitetraciclinas, metodo para su producciony composicion farmaceutica que las contiene. | |
BR0015533A (pt) | Iduronidase-alfa-l recombinante, métodos para sua produção e purificação e métodos para tratamento de doenças causadas por deficiências da mesma | |
FR2723091B1 (fr) | Tetrahydropyridine-(6,4-hydroxypiperidine) alkylazoles | |
FI952148A (fi) | Geenitekninen menetelmä ja isäntä ksylitolin valmistamiseksi | |
YU46963B (sh) | Postupak za dobijanje supstituisanih tetralina hromana i srodnih jedinjenja | |
ES2063261T3 (es) | 1-(3-(heteroarilmetoxi)fenil) alcanoles sustituidos y compuestos relacionados en el tratamiento de asma, artritis y enfermedades relacionadas. | |
ATE206394T1 (de) | Neue vitamin-d-analoga | |
ES2108004T3 (es) | Nuevas alquil piperidinas sustituidas y su empleo como inhibidores de la sintesis de colesterol. |